This antibody-drug treatment represents a novel step forward in the therapy of relapsed blood disease, mainly aggressive myeloblastic malignancy (AML). This novel antibody-drug combines a targeted antibody aimed to https://gorillasocialwork.com/story26807177/this-antibody-drug-ozogamicin-a-detailed-analysis